1711 ANALYSIS OF PATIENTS WITH BLADDER CANCER INVOLVING LYMPH NODES ABOVE THE COMMON ILIAC BIFURCATION: IS CURE POSSIBLE WITH EXTENDED LYMPHADENECTOMY?

Lambros Stamatakis,Robert Freundlich,Guilherme Godoy,Guoqing Chen,Anuja Mital,Jeffrey Shoss,Ramiro Madden-Fuentes,Seth P. Lerner
DOI: https://doi.org/10.1016/j.juro.2010.02.1558
2010-01-01
Abstract:You have accessJournal of UrologyBladder Cancer: Invasive/Metastatic Disease II1 Apr 20101711 ANALYSIS OF PATIENTS WITH BLADDER CANCER INVOLVING LYMPH NODES ABOVE THE COMMON ILIAC BIFURCATION: IS CURE POSSIBLE WITH EXTENDED LYMPHADENECTOMY? Lambros Stamatakis, Robert Freundlich, Guilherme Godoy, Guoqing Chen, Anuja Mital, Jeffrey Shoss, Ramiro Madden-Fuentes, and Seth P. Lerner Lambros StamatakisLambros Stamatakis More articles by this author , Robert FreundlichRobert Freundlich More articles by this author , Guilherme GodoyGuilherme Godoy More articles by this author , Guoqing ChenGuoqing Chen More articles by this author , Anuja MitalAnuja Mital More articles by this author , Jeffrey ShossJeffrey Shoss More articles by this author , Ramiro Madden-FuentesRamiro Madden-Fuentes More articles by this author , and Seth P. LernerSeth P. Lerner More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.1558AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Lymphadenectomy at the time of radical cystectomy (RC) provides accurate disease staging and locoregional cancer control in patients with urothelial carcinoma (UC) of the bladder. Despite data reporting improved lymph node (LN) yield and pathologic staging, extended LN dissection (eLND) continues to be underutilized. We sought to analyze the cause-specific survival (CSS) and overall survival (OS) of a subset of patients with LN involvement at or above the common iliac (CI) bifurcation who underwent an eLND. METHODS An IRB approved institutional database was used to identify patients who underwent RC by a single surgeon (SPL) for bladder UC from 1996-2009. All patients underwent eLND, defined as a superior dissection boundary at or above the aortic bifurcation and included presacral nodes. LN packets were grouped into three distinct regions, designated “pelvic” (external iliac, obturator, hypogastric, and perivesical regions), “common iliac” (CI and presacral regions), and “aortic” (above the bifurcation of the aorta). Survival analyses were performed using the Kaplan-Meier method and log-rank tests. RESULTS The cohort consisted of a total of 316 consecutive patients, including 266 males (84.2%) and 50 females (15.8%) with a median age of 67.5 years (IQR 59, 74). eLND resulted in the removal of a median number of 28 LNs (range 2-80). LN metastases were found in 78 patients (24.7%), of whom 35 (44.9%) had one or more positive LNs at or above the CI bifurcation. Median follow-up was 28 months (range 0.7-270 months). The estimated 5-year CSS and OS for those patients with pelvic-only LN involvement were 43.7% and 54.1%, respectively. Likewise, the estimated 5-year CSS and OS for those patients with LN involvement at or above the CI bifurcation were 26.6% and 36.6%, respectively. There was no significant difference in CSS and OS between these two groups (log-rank p=0.12 and p=0.27, respectively). CONCLUSIONS A significant subset of patients with node-positive bladder UC have LN metastases above the CI bifurcation and may be underserved with a pelvic-only lymphadenectomy. eLND provides accurate staging and cancer control for disease that would have otherwise been missed with a more limited dissection template. Our data suggests that patients with positive LNs above the CI bifurcation may have lower survival probability than patients with LN metastases limited to the true pelvis, but are potentially curable. Prospective trials are needed to determine the survival benefit with eLND and peri-operative chemotherapy. Houston, TX© 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e660-e661 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Lambros Stamatakis More articles by this author Robert Freundlich More articles by this author Guilherme Godoy More articles by this author Guoqing Chen More articles by this author Anuja Mital More articles by this author Jeffrey Shoss More articles by this author Ramiro Madden-Fuentes More articles by this author Seth P. Lerner More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?